Data as of Jan 28
| -0.01 / -1.61%|
The 2 analysts offering 12-month price forecasts for Cyclacel Pharmaceuticals Inc have a median target of 9.50, with a high estimate of 10.00 and a low estimate of 9.00. The median estimate represents a +1,457.38% increase from the last price of 0.61.
The current consensus among 2 polled investment analysts is to Buy stock in Cyclacel Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.